Clinical Usefulness of the VS Classification System Using Magnifying Endoscopy with Blue Laser Imaging for Early Gastric Cancer

Yoshikazu Yoshifuku, Yoji Sanomura, Shiro Oka, Kazutaka Kuroki, Mio Kurihara, Takeshi Mizumoto, Yuji Urabe, Toru Hiyama, Shinji Tanaka, Kazuaki Chayama, Yoshikazu Yoshifuku, Yoji Sanomura, Shiro Oka, Kazutaka Kuroki, Mio Kurihara, Takeshi Mizumoto, Yuji Urabe, Toru Hiyama, Shinji Tanaka, Kazuaki Chayama

Abstract

Background: Blue laser imaging (BLI) enables the acquisition of more information from tumors' surfaces compared with white light imaging. Few reports confirm the validity of magnifying endoscopy (ME) with BLI (ME-BLI) for early gastric cancer (EGC). We aimed to assess the detailed endoscopic findings from EGCs using ME-BLI.

Methods: We enrolled 386 consecutive patients with 417 EGCs that were diagnosed using ME-BLI and resected by endoscopic submucosal dissection. Using the VS classification system, three highly experienced endoscopists (HEEs) and three less experienced endoscopists (LEEs) evaluated the demarcation line (DL), microsurface pattern (MSP), and microvascular pattern (MVP) within the endoscopic images of EGCs obtained using ME-BLI, assigning high-confidence (HC) or low-confidence (LC) levels. We investigated the clinicopathological features associated with each confidence level.

Results: The HEEs' evaluations determined the presence of DL in 99%, irregular MSP in 96%, and irregular MVP in 96%, and the LEEs' evaluations determined the presence of DL in 98%, irregular MSP in 95%, and irregular MVP in 95% of the EGCs. When DL was present, HC levels in the Helicobacter pylori- (H. pylori-) eradicated group and noneradicated group were evident in 65% and 89%, a difference that was significant (p < 0.001).

Conclusions: In the diagnosis of EGC with ME-BLI, the VS classification system with ME-NBI can be applied, but identifying the DL after H. pylori was difficult.

Figures

Figure 1
Figure 1
Endoscopic images of the VS classification system using ME-BLI.

References

    1. Ferlay J., Shin H. R., Bray F., Forman D., Mathers C., Parkin D. M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer. 2010;127(12):2893–2917. doi: 10.1002/ijc.25516.
    1. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3) Gastric Cancer. 2011;14(2):113–123. doi: 10.1007/s10120-011-0042-4.
    1. Oka S., Tanaka S., Kaneko I., et al. Advantage of endoscopic submucosal dissection compared with EMR for early gastric cancer. Gastrointestinal Endoscopy. 2006;64(6):877–883. doi: 10.1016/j.gie.2006.03.932.
    1. Ono H., Kondo H., Gotoda T., et al. Endoscopic mucosal resection for treatment of early gastric cancer. Gut. 2001;48(2):225–229. doi: 10.1136/gut.48.2.225.
    1. Gotoda T. Endoscopic resection of early gastric cancer. Gastric Cancer. 2007;10(1):1–11. doi: 10.1007/s10120-006-0408-1.
    1. Imagawa A., Okada H., Kawahara Y., et al. Endoscopic submucosal dissection for early gastric cancer: results and degrees of technical difficulty as well as success. Endoscopy. 2006;38(10):987–990. doi: 10.1055/s-2006-944716.
    1. Gotoda T., Yamamoto H., Soetikno R. M. Endoscopic submucosal dissection of early gastric cancer. Journal of Gastroenterology. 2006;41(10):929–942. doi: 10.1007/s00535-006-1954-3.
    1. Ida K., Hashimoto Y., Takeda S., Murakami K., Kawai K. Endoscopic diagnosis of gastric cancer with dye scattering. The American Journal of Gastroenterology. 1975;63(4):316–320.
    1. Yoshinaga S., Gotoda T., Oda I. Clinical imaging of early gastric cancers—conventional endoscopy: including chromoendoscopy using indigo carmine. Stomach Intestine. 2009;44(4):650–662. doi: 10.1121/1.4978754. [Article in Japanese]
    1. Iizuka T., Kikuchi D., Hoteya S., Yahagi N. The acetic acid + indigocarmine method in the delineation of gastric cancer. Journal of Gastroenterology and Hepatology. 2008;23(9):1358–1361. doi: 10.1111/j.1440-1746.2008.05528.x.
    1. Sakai Y., Eto R., Kasanuki J., et al. Chromoendoscopy with indigo carmine dye added to acetic acid in the diagnosis of gastric neoplasia: a prospective comparative study. Gastrointestinal Endoscopy. 2008;68(4):635–641. doi: 10.1016/j.gie.2008.03.1065.
    1. Kawahara Y., Takenaka R., Okada H., et al. Novel chromoendoscopic method using an acetic acid-indigocarmine mixture for diagnostic accuracy in delineating the margin of early gastric cancers. Digestive Endoscopy. 2009;21(1):14–19. doi: 10.1111/j.1443-1661.2008.00824.x.
    1. Oka S., Tanaka S., Numata N., Sanomura Y., Chayama K. Endoscopic diagnosis of early gastric cancer. Nihon Rinsho. 2012;70(10):1742–1747. doi: 10.4049/jimmunol.1601607. [Article in Japanese]
    1. Yao K., Anagnostopoulos G. K., Ragunath K. Magnifying endoscopy for diagnosing and delineating early gastric cancer. Endoscopy. 2009;41(5):462–467. doi: 10.1055/s-0029-1214594.
    1. Mouri R., Yoshida S., Chayama K., Tanaka S., Oka S., Yoshihara M. Evaluation and validation of computed virtual chromoendoscopy in early gastric cancer. Gastrointestinal Endoscopy. 2009;69(6):1052–1058. doi: 10.1016/j.gie.2008.08.032.
    1. Osawa H., Yamamoto H., Satoh K., Sugano K. Diagnosis of extent of early gastric cancer using flexible spectral imaging color enhancement. World Journal of Gastrointestinal Endoscopy. 2012;4(8):356–361. doi: 10.4253/wjge.v4.i8.356.
    1. Dohi O., Yagi N., Majima A., et al. Diagnostic ability of magnifying endoscopy with blue laser imaging for early gastric cancer: a prospective study. Gastric Cancer. 2017;20(2):297–303. doi: 10.1007/s10120-016-0620-6. [Epub ahead of print]
    1. Yamada S., Doyama H., Yao K., et al. An efficient diagnostic strategy for small, depressed early gastric cancer with magnifying narrow-band imaging: a post-hoc analysis of a prospective randomized controlled trial. Gastrointestinal Endoscopy. 2014;79(1):55–63. doi: 10.1016/j.gie.2013.07.008.
    1. Ezoe Y., Muto M., Uedo N., et al. Magnifying narrowband imaging is more accurate than conventional white-light imaging in diagnosis of gastric mucosal cancer. Gastroenterology. 2011;141(6):2017–2025. doi: 10.1053/j.gastro.2011.08.007.
    1. Kanesaka T., Uedo N., Yao K., et al. A significant feature of microvessels in magnifying narrow-band imaging for diagnosis of early gastric cancer. Endoscopy International Open. 2015;3(6):E590–E596. doi: 10.1055/s-0034-1392608.
    1. Uchita K., Yao K., Uedo N., et al. Highest power magnification with narrow-band imaging is useful for improving diagnostic performance for endoscopic delineation of early gastric cancers. BMC Gastroenterology. 2015;15(1):p. 155. doi: 10.1186/s12876-015-0385-0.
    1. Nagahama T., Yao K., Maki S., et al. Usefulness of magnifying endoscopy with narrow-band imaging for determining the horizontal extent of early gastric cancer when there is an unclear margin by chromoendoscopy (with video) Gastrointestinal Endoscopy. 2011;74(6):1259–1267. doi: 10.1016/j.gie.2011.09.005.
    1. Kiyotoki S., Nishikawa J., Satake M., et al. Usefulness of magnifying endoscopy with narrow-band imaging for determining gastric tumor margin. Journal of Gastroenterology and Hepatology. 2010;25(10):1636–1641. doi: 10.1111/j.1440-1746.2010.06379.x.
    1. Nonaka K., Namoto M., Kitada H., et al. Usefulness of the DL in ME with NBI for determining the expanded area of early-stage differentiated gastric carcinoma. World Journal of Gastrointestinal Endoscopy. 2012;4(8):362–367. doi: 10.4253/wjge.v4.i8.362.
    1. Takeuchi M., Kobayashi M., Hashimoto S., Narisawa R., Aoyagi Y. Usefulness of magnifying narrow band imaging for assessing lateral tumor extent of early gastric cancer: a case report. Digestive Endoscopy. 2011;23(Supplement 1):86–88. doi: 10.1111/j.1443-1661.2011.01111.x.
    1. Horiuchi Y., Fujisaki J., Yamamoto N., et al. Accuracy of diagnostic demarcation of undifferentiated-type early gastric cancers for magnifying endoscopy with narrow-band imaging: endoscopic submucosal dissection cases. Gastric Cancer. 2016;19(2):515–523. doi: 10.1007/s10120-015-0488-x.
    1. Forman D., Newell D. G., Fullerton F., et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ. 1991;302(6788):1302–1305. doi: 10.1136/bmj.302.6788.1302.
    1. Parsonnet J., Friedman G. D., Vandersteen D. P., et al. Helicobacter pylori infection and the risk of gastric carcinoma. The New England Journal of Medicine. 1991;325(16):1127–1131. doi: 10.1056/NEJM199110173251603.
    1. Nomura A., Stemmermann G. N., Chyou P. H., Kato I., Perez-Perez G. I., Blaser M. J. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. The New England Journal of Medicine. 1991;325(16):1132–1136. doi: 10.1056/NEJM199110173251604.
    1. Uemura N., Okamoto S., Yamamoto S., et al. Helicobacter pylori infection and the development of gastric cancer. The New England Journal of Medicine. 2001;345(11):784–789. doi: 10.1056/NEJMoa001999.
    1. Kamada T., Hata J., Sugiu K., et al. Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: results from a 9-year prospective follow-up study in Japan. Alimentary Pharmacology & Therapeutics. 2005;21(9):1121–1126. doi: 10.1111/j.1365-2036.2005.02459.x.
    1. Saka A., Yagi K., Nimura S. Endoscopic and histological features of gastric cancers after successful Helicobacter pylori eradication therapy. Gastric Cancer. 2016;19(2):524–530. doi: 10.1007/s10120-015-0479-y.
    1. Yagi K., Saka A., Nozawa Y., Nimura S. Endoscopic technique for qualitative diagnosis of gastric cancer and diagnosis of its expansion after successful Helicobacter pylori eradication therapy: focused on diagnosis by NBI magnifying endoscopy. Gastroenterological Endoscopy. 2015;57(4):1210–1218. doi: 10.11280/gee.57.1210.
    1. Kobayashi M., Hashimoto S., Nishikura K., et al. Magnifying narrow-band imaging of surface maturation in early differentiated-type gastric cancers after Helicobacter pylori eradication. Journal of Gastroenterology. 2013;48(12):1332–1342. doi: 10.1007/s00535-013-0764-7.
    1. Ito M., Tanaka S., Takata S., et al. Morphological changes in human gastric tumours after eradication therapy of Helicobacter pylori in a short-term follow-up. Alimentary Pharmacology & Therapeutics. 2005;21(5):559–566. doi: 10.1111/j.1365-2036.2005.02360.x.
    1. Kitamura Y., Ito M., Matsuo T., et al. Characteristic epithelium with low-grade atypia appears on the surface of gastric cancer after successful Helicobacter pylori eradication therapy. Helicobacter. 2014;19(4):289–295. doi: 10.1111/hel.12132.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner